Covid-19 Impact on Global Codeine Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 29-Apr-2020
No. of pages: 153
Inquire Before Buying

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Codeine 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Codeine 3900 industry.

Based on our recent survey, we have several different scenarios about the Codeine 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 313 million in 2019. The market size of Codeine 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Codeine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Codeine market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Codeine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Codeine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Codeine market, covering important regions, viz, North America, Europe, China, Japan, Middle East and India. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Codeine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Codeine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Codeine market.

The following manufacturers are covered in this report:

- Taiji

- Mallinckrodt

- TEVA

- Johnson & Johnson

- Medreich

- Sanofi Aventis

- Cipla

- Hikma

- Pharmaceutical Associates

- Novartis

- Apotex

- Mylan

- Aristo Pharma GmbH

- Lannett Company

- Laboratoire Riva

Codeine Breakdown Data by Type

- Single-ingredient Codeine

- Multi-ingredient Medications

Codeine Breakdown Data by Application

- Narcotic Analgesic

- Antitussive

- Others

Covid-19 Impact on Global Codeine Market Size, Status and Forecast 2020-2026

Table of Contents
1 Study Coverage
1.1 Codeine Product Introduction
1.2 Market Segments
1.3 Key Codeine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Codeine Market Size Growth Rate by Type
1.4.2 Single-ingredient Codeine
1.4.3 Multi-ingredient Medications
1.5 Market by Application
1.5.1 Global Codeine Market Size Growth Rate by Application
1.5.2 Narcotic Analgesic
1.5.3 Antitussive
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Codeine Industry Impact
1.6.1 How the Covid-19 is Affecting the Codeine Industry
1.6.1.1 Codeine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Codeine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Codeine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Codeine Market Size Estimates and Forecasts
2.1.1 Global Codeine Revenue 2015-2026
2.1.2 Global Codeine Sales 2015-2026
2.2 Codeine Market Size by Region: 2020 Versus 2026
2.2.1 Global Codeine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Codeine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Codeine Competitor Landscape by Players
3.1 Codeine Sales by Manufacturers
3.1.1 Codeine Sales by Manufacturers (2015-2020)
3.1.2 Codeine Sales Market Share by Manufacturers (2015-2020)
3.2 Codeine Revenue by Manufacturers
3.2.1 Codeine Revenue by Manufacturers (2015-2020)
3.2.2 Codeine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Codeine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Codeine Revenue in 2019
3.2.5 Global Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Codeine Price by Manufacturers
3.4 Codeine Manufacturing Base Distribution, Product Types
3.4.1 Codeine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Codeine Product Type
3.4.3 Date of International Manufacturers Enter into Codeine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Codeine Market Size by Type (2015-2020)
4.1.1 Global Codeine Sales by Type (2015-2020)
4.1.2 Global Codeine Revenue by Type (2015-2020)
4.1.3 Codeine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Codeine Market Size Forecast by Type (2021-2026)
4.2.1 Global Codeine Sales Forecast by Type (2021-2026)
4.2.2 Global Codeine Revenue Forecast by Type (2021-2026)
4.2.3 Codeine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Codeine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Codeine Market Size by Application (2015-2020)
5.1.1 Global Codeine Sales by Application (2015-2020)
5.1.2 Global Codeine Revenue by Application (2015-2020)
5.1.3 Codeine Price by Application (2015-2020)
5.2 Codeine Market Size Forecast by Application (2021-2026)
5.2.1 Global Codeine Sales Forecast by Application (2021-2026)
5.2.2 Global Codeine Revenue Forecast by Application (2021-2026)
5.2.3 Global Codeine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Codeine by Country
6.1.1 North America Codeine Sales by Country
6.1.2 North America Codeine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Codeine Market Facts & Figures by Type
6.3 North America Codeine Market Facts & Figures by Application
7 Europe
7.1 Europe Codeine by Country
7.1.1 Europe Codeine Sales by Country
7.1.2 Europe Codeine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Codeine Market Facts & Figures by Type
7.3 Europe Codeine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Codeine by Region
8.1.1 Asia Pacific Codeine Sales by Region
8.1.2 Asia Pacific Codeine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Codeine Market Facts & Figures by Type
8.3 Asia Pacific Codeine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Codeine by Country
9.1.1 Latin America Codeine Sales by Country
9.1.2 Latin America Codeine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Codeine Market Facts & Figures by Type
9.3 Central & South America Codeine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Codeine by Country
10.1.1 Middle East and Africa Codeine Sales by Country
10.1.2 Middle East and Africa Codeine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Codeine Market Facts & Figures by Type
10.3 Middle East and Africa Codeine Market Facts & Figures by Application
11 Company Profiles
11.1 Taiji
11.1.1 Taiji Corporation Information
11.1.2 Taiji Description, Business Overview and Total Revenue
11.1.3 Taiji Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Taiji Codeine Products Offered
11.1.5 Taiji Recent Development
11.2 Mallinckrodt
11.2.1 Mallinckrodt Corporation Information
11.2.2 Mallinckrodt Description, Business Overview and Total Revenue
11.2.3 Mallinckrodt Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Mallinckrodt Codeine Products Offered
11.2.5 Mallinckrodt Recent Development
11.3 TEVA
11.3.1 TEVA Corporation Information
11.3.2 TEVA Description, Business Overview and Total Revenue
11.3.3 TEVA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 TEVA Codeine Products Offered
11.3.5 TEVA Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Codeine Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 Medreich
11.5.1 Medreich Corporation Information
11.5.2 Medreich Description, Business Overview and Total Revenue
11.5.3 Medreich Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Medreich Codeine Products Offered
11.5.5 Medreich Recent Development
11.6 Sanofi Aventis
11.6.1 Sanofi Aventis Corporation Information
11.6.2 Sanofi Aventis Description, Business Overview and Total Revenue
11.6.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Aventis Codeine Products Offered
11.6.5 Sanofi Aventis Recent Development
11.7 Cipla
11.7.1 Cipla Corporation Information
11.7.2 Cipla Description, Business Overview and Total Revenue
11.7.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Cipla Codeine Products Offered
11.7.5 Cipla Recent Development
11.8 Hikma
11.8.1 Hikma Corporation Information
11.8.2 Hikma Description, Business Overview and Total Revenue
11.8.3 Hikma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Hikma Codeine Products Offered
11.8.5 Hikma Recent Development
11.9 Pharmaceutical Associates
11.9.1 Pharmaceutical Associates Corporation Information
11.9.2 Pharmaceutical Associates Description, Business Overview and Total Revenue
11.9.3 Pharmaceutical Associates Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pharmaceutical Associates Codeine Products Offered
11.9.5 Pharmaceutical Associates Recent Development
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Description, Business Overview and Total Revenue
11.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis Codeine Products Offered
11.10.5 Novartis Recent Development
11.1 Taiji
11.1.1 Taiji Corporation Information
11.1.2 Taiji Description, Business Overview and Total Revenue
11.1.3 Taiji Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Taiji Codeine Products Offered
11.1.5 Taiji Recent Development
11.12 Mylan
11.12.1 Mylan Corporation Information
11.12.2 Mylan Description, Business Overview and Total Revenue
11.12.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Mylan Products Offered
11.12.5 Mylan Recent Development
11.13 Aristo Pharma GmbH
11.13.1 Aristo Pharma GmbH Corporation Information
11.13.2 Aristo Pharma GmbH Description, Business Overview and Total Revenue
11.13.3 Aristo Pharma GmbH Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Aristo Pharma GmbH Products Offered
11.13.5 Aristo Pharma GmbH Recent Development
11.14 Lannett Company
11.14.1 Lannett Company Corporation Information
11.14.2 Lannett Company Description, Business Overview and Total Revenue
11.14.3 Lannett Company Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Lannett Company Products Offered
11.14.5 Lannett Company Recent Development
11.15 Laboratoire Riva
11.15.1 Laboratoire Riva Corporation Information
11.15.2 Laboratoire Riva Description, Business Overview and Total Revenue
11.15.3 Laboratoire Riva Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Laboratoire Riva Products Offered
11.15.5 Laboratoire Riva Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Codeine Market Estimates and Projections by Region
12.1.1 Global Codeine Sales Forecast by Regions 2021-2026
12.1.2 Global Codeine Revenue Forecast by Regions 2021-2026
12.2 North America Codeine Market Size Forecast (2021-2026)
12.2.1 North America: Codeine Sales Forecast (2021-2026)
12.2.2 North America: Codeine Revenue Forecast (2021-2026)
12.2.3 North America: Codeine Market Size Forecast by Country (2021-2026)
12.3 Europe Codeine Market Size Forecast (2021-2026)
12.3.1 Europe: Codeine Sales Forecast (2021-2026)
12.3.2 Europe: Codeine Revenue Forecast (2021-2026)
12.3.3 Europe: Codeine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Codeine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Codeine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Codeine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Codeine Market Size Forecast by Region (2021-2026)
12.5 Latin America Codeine Market Size Forecast (2021-2026)
12.5.1 Latin America: Codeine Sales Forecast (2021-2026)
12.5.2 Latin America: Codeine Revenue Forecast (2021-2026)
12.5.3 Latin America: Codeine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Codeine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Codeine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Codeine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Codeine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Codeine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Codeine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Codeine Market Segments
Table 2. Ranking of Global Top Codeine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Codeine Market Size Growth Rate by Type 2020-2026 (M Units) & (US$ Million)
Table 4. Major Manufacturers of Single-ingredient Codeine
Table 5. Major Manufacturers of Multi-ingredient Medications
Table 6. COVID-19 Impact Global Market: (Four Codeine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Codeine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Codeine Players to Combat Covid-19 Impact
Table 11. Global Codeine Market Size Growth Rate by Application 2020-2026 (M Units)
Table 12. Global Codeine Market Size by Region (M Units) & (US$ Million): 2020 VS 2026
Table 13. Global Codeine Sales by Regions 2015-2020 (M Units)
Table 14. Global Codeine Sales Market Share by Regions (2015-2020)
Table 15. Global Codeine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Codeine Sales by Manufacturers (2015-2020) (M Units)
Table 17. Global Codeine Sales Share by Manufacturers (2015-2020)
Table 18. Global Codeine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Codeine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Codeine as of 2019)
Table 20. Codeine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Codeine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Codeine Price (2015-2020) (USD/Unit)
Table 23. Codeine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Codeine Product Type
Table 25. Date of International Manufacturers Enter into Codeine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Codeine Sales by Type (2015-2020) (M Units)
Table 28. Global Codeine Sales Share by Type (2015-2020)
Table 29. Global Codeine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Codeine Revenue Share by Type (2015-2020)
Table 31. Codeine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Codeine Sales by Application (2015-2020) (M Units)
Table 33. Global Codeine Sales Share by Application (2015-2020)
Table 34. North America Codeine Sales by Country (2015-2020) (M Units)
Table 35. North America Codeine Sales Market Share by Country (2015-2020)
Table 36. North America Codeine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Codeine Revenue Market Share by Country (2015-2020)
Table 38. North America Codeine Sales by Type (2015-2020) (M Units)
Table 39. North America Codeine Sales Market Share by Type (2015-2020)
Table 40. North America Codeine Sales by Application (2015-2020) (M Units)
Table 41. North America Codeine Sales Market Share by Application (2015-2020)
Table 42. Europe Codeine Sales by Country (2015-2020) (M Units)
Table 43. Europe Codeine Sales Market Share by Country (2015-2020)
Table 44. Europe Codeine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Codeine Revenue Market Share by Country (2015-2020)
Table 46. Europe Codeine Sales by Type (2015-2020) (M Units)
Table 47. Europe Codeine Sales Market Share by Type (2015-2020)
Table 48. Europe Codeine Sales by Application (2015-2020) (M Units)
Table 49. Europe Codeine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Codeine Sales by Region (2015-2020) (M Units)
Table 51. Asia Pacific Codeine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Codeine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Codeine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Codeine Sales by Type (2015-2020) (M Units)
Table 55. Asia Pacific Codeine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Codeine Sales by Application (2015-2020) (M Units)
Table 57. Asia Pacific Codeine Sales Market Share by Application (2015-2020)
Table 58. Latin America Codeine Sales by Country (2015-2020) (M Units)
Table 59. Latin America Codeine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Codeine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Codeine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Codeine Sales by Type (2015-2020) (M Units)
Table 63. Latin America Codeine Sales Market Share by Type (2015-2020)
Table 64. Latin America Codeine Sales by Application (2015-2020) (M Units)
Table 65. Latin America Codeine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Codeine Sales by Country (2015-2020) (M Units)
Table 67. Middle East and Africa Codeine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Codeine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Codeine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Codeine Sales by Type (2015-2020) (M Units)
Table 71. Middle East and Africa Codeine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Codeine Sales by Application (2015-2020) (M Units)
Table 73. Middle East and Africa Codeine Sales Market Share by Application (2015-2020)
Table 74. Taiji Corporation Information
Table 75. Taiji Description and Major Businesses
Table 76. Taiji Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Taiji Product
Table 78. Taiji Recent Development
Table 79. Mallinckrodt Corporation Information
Table 80. Mallinckrodt Description and Major Businesses
Table 81. Mallinckrodt Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Mallinckrodt Product
Table 83. Mallinckrodt Recent Development
Table 84. TEVA Corporation Information
Table 85. TEVA Description and Major Businesses
Table 86. TEVA Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. TEVA Product
Table 88. TEVA Recent Development
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Description and Major Businesses
Table 91. Johnson & Johnson Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Recent Development
Table 94. Medreich Corporation Information
Table 95. Medreich Description and Major Businesses
Table 96. Medreich Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Medreich Product
Table 98. Medreich Recent Development
Table 99. Sanofi Aventis Corporation Information
Table 100. Sanofi Aventis Description and Major Businesses
Table 101. Sanofi Aventis Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Sanofi Aventis Product
Table 103. Sanofi Aventis Recent Development
Table 104. Cipla Corporation Information
Table 105. Cipla Description and Major Businesses
Table 106. Cipla Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Cipla Product
Table 108. Cipla Recent Development
Table 109. Hikma Corporation Information
Table 110. Hikma Description and Major Businesses
Table 111. Hikma Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Hikma Product
Table 113. Hikma Recent Development
Table 114. Pharmaceutical Associates Corporation Information
Table 115. Pharmaceutical Associates Description and Major Businesses
Table 116. Pharmaceutical Associates Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Pharmaceutical Associates Product
Table 118. Pharmaceutical Associates Recent Development
Table 119. Novartis Corporation Information
Table 120. Novartis Description and Major Businesses
Table 121. Novartis Codeine Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Novartis Product
Table 123. Novartis Recent Development
Table 124. Apotex Corporation Information
Table 125. Apotex Description and Major Businesses
Table 126. Apotex Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Apotex Product
Table 128. Apotex Recent Development
Table 129. Mylan Corporation Information
Table 130. Mylan Description and Major Businesses
Table 131. Mylan Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Mylan Product
Table 133. Mylan Recent Development
Table 134. Aristo Pharma GmbH Corporation Information
Table 135. Aristo Pharma GmbH Description and Major Businesses
Table 136. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Aristo Pharma GmbH Product
Table 138. Aristo Pharma GmbH Recent Development
Table 139. Lannett Company Corporation Information
Table 140. Lannett Company Description and Major Businesses
Table 141. Lannett Company Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Lannett Company Product
Table 143. Lannett Company Recent Development
Table 144. Laboratoire Riva Corporation Information
Table 145. Laboratoire Riva Description and Major Businesses
Table 146. Laboratoire Riva Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Laboratoire Riva Product
Table 148. Laboratoire Riva Recent Development
Table 149. Global Codeine Sales Forecast by Regions (2021-2026) (M Units)
Table 150. Global Codeine Sales Market Share Forecast by Regions (2021-2026)
Table 151. Global Codeine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 152. Global Codeine Revenue Market Share Forecast by Regions (2021-2026)
Table 153. North America: Codeine Sales Forecast by Country (2021-2026) (M Units)
Table 154. North America: Codeine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Europe: Codeine Sales Forecast by Country (2021-2026) (M Units)
Table 156. Europe: Codeine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Asia Pacific: Codeine Sales Forecast by Region (2021-2026) (M Units)
Table 158. Asia Pacific: Codeine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Latin America: Codeine Sales Forecast by Country (2021-2026) (M Units)
Table 160. Latin America: Codeine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 161. Middle East and Africa: Codeine Sales Forecast by Country (2021-2026) (M Units)
Table 162. Middle East and Africa: Codeine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 164. Key Challenges
Table 165. Market Risks
Table 166. Main Points Interviewed from Key Codeine Players
Table 167. Codeine Customers List
Table 168. Codeine Distributors List
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Codeine Product Picture
Figure 2. Global Codeine Sales Market Share by Type in 2020 & 2026
Figure 3. Single-ingredient Codeine Product Picture
Figure 4. Multi-ingredient Medications Product Picture
Figure 5. Global Codeine Sales Market Share by Application in 2020 & 2026
Figure 6. Narcotic Analgesic
Figure 7. Antitussive
Figure 8. Others
Figure 9. Codeine Report Years Considered
Figure 10. Global Codeine Market Size 2015-2026 (US$ Million)
Figure 11. Global Codeine Sales 2015-2026 (M Units)
Figure 12. Global Codeine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Codeine Sales Market Share by Region (2015-2020)
Figure 14. Global Codeine Sales Market Share by Region in 2019
Figure 15. Global Codeine Revenue Market Share by Region (2015-2020)
Figure 16. Global Codeine Revenue Market Share by Region in 2019
Figure 17. Global Codeine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Codeine Revenue in 2019
Figure 19. Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Codeine Sales Market Share by Type (2015-2020)
Figure 21. Global Codeine Sales Market Share by Type in 2019
Figure 22. Global Codeine Revenue Market Share by Type (2015-2020)
Figure 23. Global Codeine Revenue Market Share by Type in 2019
Figure 24. Global Codeine Market Share by Price Range (2015-2020)
Figure 25. Global Codeine Sales Market Share by Application (2015-2020)
Figure 26. Global Codeine Sales Market Share by Application in 2019
Figure 27. Global Codeine Revenue Market Share by Application (2015-2020)
Figure 28. Global Codeine Revenue Market Share by Application in 2019
Figure 29. North America Codeine Sales Growth Rate 2015-2020 (M Units)
Figure 30. North America Codeine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Codeine Sales Market Share by Country in 2019
Figure 32. North America Codeine Revenue Market Share by Country in 2019
Figure 33. U.S. Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 34. U.S. Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 36. Canada Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Codeine Market Share by Type in 2019
Figure 38. North America Codeine Market Share by Application in 2019
Figure 39. Europe Codeine Sales Growth Rate 2015-2020 (M Units)
Figure 40. Europe Codeine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Codeine Sales Market Share by Country in 2019
Figure 42. Europe Codeine Revenue Market Share by Country in 2019
Figure 43. Germany Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 44. Germany Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 46. France Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 48. U.K. Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 50. Italy Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 52. Russia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Codeine Market Share by Type in 2019
Figure 54. Europe Codeine Market Share by Application in 2019
Figure 55. Asia Pacific Codeine Sales Growth Rate 2015-2020 (M Units)
Figure 56. Asia Pacific Codeine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Codeine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Codeine Revenue Market Share by Region in 2019
Figure 59. China Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 60. China Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 62. Japan Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 64. South Korea Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 66. India Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 68. Australia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 70. Taiwan Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 72. Indonesia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 74. Thailand Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 76. Malaysia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 78. Philippines Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 80. Vietnam Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Codeine Market Share by Type in 2019
Figure 82. Asia Pacific Codeine Market Share by Application in 2019
Figure 83. Latin America Codeine Sales Growth Rate 2015-2020 (M Units)
Figure 84. Latin America Codeine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Codeine Sales Market Share by Country in 2019
Figure 86. Latin America Codeine Revenue Market Share by Country in 2019
Figure 87. Mexico Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 88. Mexico Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 90. Brazil Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 92. Argentina Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Codeine Market Share by Type in 2019
Figure 94. Latin America Codeine Market Share by Application in 2019
Figure 95. Middle East and Africa Codeine Sales Growth Rate 2015-2020 (M Units)
Figure 96. Middle East and Africa Codeine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Codeine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Codeine Revenue Market Share by Country in 2019
Figure 99. Turkey Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 100. Turkey Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 102. Saudi Arabia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 104. UAE Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Codeine Market Share by Type in 2019
Figure 106. Middle East and Africa Codeine Market Share by Application in 2019
Figure 107. Taiji Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Medreich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Sanofi Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Pharmaceutical Associates Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Aristo Pharma GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Lannett Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Laboratoire Riva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. North America Codeine Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 123. North America Codeine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Europe Codeine Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 125. Europe Codeine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Asia Pacific Codeine Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 127. Asia Pacific Codeine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Latin America Codeine Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 129. Latin America Codeine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Middle East and Africa Codeine Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 131. Middle East and Africa Codeine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Porter's Five Forces Analysis
Figure 133. Channels of Distribution
Figure 134. Distributors Profiles
Figure 135. Bottom-up and Top-down Approaches for This Report
Figure 136. Data Triangulation
Figure 137. Key Executives Interviewed
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs